Shandong Sinobioway Biomedicine News

Unnamed Pharmaceuticals: Explanation and Verification Opinions of the Supervisory Board on the Publication of the Company\'s 2024 Stock Option Incentive Plan Incentive List

00:00

Unnamed Pharmaceuticals: Announcement on the progress of the transfer of shares in participating companies through public listing

Dec 7 00:00

Unnamed Pharmaceuticals: An indicative announcement on the adoption of an autonomous exercise model during the first exercise period of the 2023 Stock Options Incentive Plan

Dec 6 00:00

Unnamed Pharmaceuticals: Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan Implementation Assessment Measures

Dec 3 00:00

Unnamed Pharmaceutical: Notice on requesting the shareholders\' meeting to authorize the board of directors to handle matters relating to the company\'s 2024 stock option incentive plan

Dec 3 00:00

Unnamed Pharmaceuticals: Supervisory Board\'s Review Opinions on Matters Related to the 2024 Stock Options Incentive Plan

Dec 3 00:00

Unnamed Medicine: Legal Opinion of Zhejiang Tianzu (Shenzhen) Law Firm on Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan (Draft)

Dec 3 00:00

Unnamed Pharmaceuticals: Draft Equity Incentive Plan Self-Inspection Form

Dec 3 00:00

Unnamed Pharmaceuticals: 2024 Stock Option Incentive Plan Incentive List

Dec 3 00:00

Unnamed Pharmaceuticals: Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan Draft (Summary)

Dec 3 00:00

Weiming Pharmaceutical: Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan (Draft)

Dec 3 00:00

Unnamed Pharmaceuticals: Announcement on the progress of the transfer of shares in participating companies through public listing

Nov 20 00:00

Unnamed Pharmaceuticals: 2024-053 Announcement on the progress of the proposed transfer of shares in participating companies through public listing

Oct 18 00:00

Unnamed Pharmaceuticals: Announcement on the completion of cancellation of some stock options in the 2023 Stock Options Incentive Plan

Oct 16 00:00

Unnamed Pharmaceuticals: Announcement on the progress of the proposed transfer of shares in participating companies through public listing

Sep 28 00:00

Unnamed Pharmaceuticals: Announcement on Supplementary Pledges for Company Shareholders\' Shares

Sep 27 00:00

Unnamed Pharmaceuticals: Announcement on the progress of the proposed transfer of shares in participating companies through public listing

Sep 21 00:00

Unnamed Pharmaceuticals: Announcement on Cancelling Some Stock Options of the 2023 Stock Options Incentive Plan and Adjusting the List of Incentive Targets

Aug 28 00:00

Unnamed Pharmaceuticals: Supplementary Announcement on the Achievement of the Enforcement Conditions for the First Exercise Period of the 2023 Stock Options Incentive Plan

Aug 28 00:00

Unnamed Medicine: Legal Opinion of Zhejiang Tianzu (Shenzhen) Law Firm on Shandong Weiming Biomedical Co., Ltd. canceling some stock options and adjusting the list of incentive recipients in the 2023 Stock Option Incentive Plan

Aug 28 00:00